Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Application
L-leucine has been used as a hypertrophic agent to monitor its effects on myotubes. It has also been used as a component of PMG media for culturing yeast.
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organic acids and derivatives |
| Klasse | Carboxylic acids and derivatives |
| Subclass | Amino acids, peptides, and analogues |
| Intermediate Tree Nodes | Amino acids and derivatives - Alpha amino acids and derivatives |
| Direct Parent | Leucine and derivatives |
| Alternative Parents | L-alpha-amino acids Methyl-branched fatty acids Amino acids Monocarboxylic acids and derivatives Carboxylic acids Organopnictogen compounds Organic oxides Monoalkylamines Hydrocarbon derivatives Carbonyl compounds |
| Molecular Framework | Aliphatic acyclic compounds |
| Substituents | Leucine or derivatives - Alpha-amino acid - L-alpha-amino acid - Branched fatty acid - Methyl-branched fatty acid - Fatty acid - Fatty acyl - Amino acid - Monocarboxylic acid or derivatives - Carboxylic acid - Organic oxide - Organopnictogen compound - Primary amine - Organooxygen compound - Organonitrogen compound - Primary aliphatic amine - Carbonyl group - Organic oxygen compound - Amine - Organic nitrogen compound - Hydrocarbon derivative - Aliphatic acyclic compound |
| Beschreibung | This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
| External Descriptors | Common amino acids |
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Datum | Artikel |
|---|---|---|---|
| Certificate of Analysis | Aug 17, 2026 | L433130 | |
| Certificate of Analysis | Apr 25, 2026 | L433130 | |
| Certificate of Analysis | Mar 11, 2026 | L433130 | |
| Certificate of Analysis | Mar 11, 2026 | L433130 | |
| Certificate of Analysis | Mar 11, 2026 | L433130 | |
| Certificate of Analysis | Mar 11, 2026 | L433130 | |
| Certificate of Analysis | Mar 11, 2026 | L433130 | |
| Certificate of Analysis | May 12, 2023 | L433130 | |
| Certificate of Analysis | May 12, 2023 | L433130 |
| Löslichkeit | 1 M HCl: 50mg/mL |
|---|---|
| Empfindlichkeit | Sensitive to light; Sensitivity to humidity |
| Spezifische Drehung [α] | [α]20/D +15.5±0.5°, c = 5% in 5 M HCl |
| Siedepunkt (°C) | 122-134 °C |
| Schmelzpunkt (°C) | 270-340 °C (decomposition) |
| Molekulargewicht | 131.17 |
| XLogP3 | -1.500 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 131.095 Da |
| Monoisotopic Mass | 131.095 Da |
| Topological Polar Surface Area | 63.300 Ų |
| Heavy Atom Count | 9 |
| Formal Charge | 0 |
| Complexity | 101.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |
H315:Causes skin irritation
H319:Causes serious eye irritation
H335:May cause respiratory irritation
P261:Avoid breathing dust/fume/gas/mist/vapors/spray.
P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.
No item‑specific, validated application protocols are provided for this product. Typical laboratory uses include:
For detailed, step‑by‑step protocols, consult standard cell culture and peptide synthesis references and adapt to your system. Always verify compatibility (endotoxin/bioburden, osmolarity) with your specific application.
General biochemistry (literature; not product specifications or clinical claims):
Note: For research use only (per Product Data). No medical or clinical claims are made or implied.
Applicability: L‑Leucine is not a standard laboratory buffer. As a zwitterionic amino acid with pKa ≈ 2.36 (COOH) and 9.60 (NH3+), it exhibits minimal buffering capacity around its isoelectric point (pI ≈ 5.98) compared to dedicated buffers.
When it may be used (literature):
Practical notes:
For robust buffering between pH 6–8, select Good’s buffers (HEPES, MOPS, PIPES) or phosphate. Use leucine primarily for nutritional/biophysical roles rather than as a buffer.
Context: L‑Leucine itself is a biogenic, renewable molecule typically produced by fermentation, aligning well with green chemistry principles. Greener choices focus on solvent systems and protection strategies in its use.
Greener handling of L‑Leucine (literature/guidance):
Comparison examples (literature; tradeoffs):
Process intensification:
Always confirm material compatibility with the target application (especially for cell culture) and assess residual solvent limits against compendial guidelines.
Scope (formulation/manufacturing context only; no therapeutic claims):
Grade relevance (item-specific): USP/JP/Ph.Eur. listings indicate suitability for use as an excipient or active ingredient in compliance with pharmacopeial quality tests when supported by full GMP controls. Animal Free and cell culture suitability benefit upstream bioprocess development and ancillary materials.
Typical excipient roles (literature):
Manufacturing considerations (literature):
For clinical/commercial use, implement GMP sourcing and perform full excipient compatibility and stability studies.
Item-specific (from Product Data):
Literature/Computed (general reference values; not item specifications):
Notes:
Item-specific certifications/grades (from Product Data):
What these grades imply (general guidance):
Not provided for this item (do not assume; verify on CoA): water content, specific optical rotation range, residue on ignition/ash, heavy metal limits, UV cutoff, residual solvents, and endotoxin/bioburden.
Focus: As a chiral, bifunctional building block, L‑Leucine is central to peptide chemistry, bioconjugation, and as a component of cell culture media (nutritional nitrogen/carbon source).
Cell culture/media (item intent): For Cell Culture grade supports use in basal media and feeds; leucine availability modulates growth, productivity, and recombinant protein quality attributes. Typical use is gram‑per‑liter concentrations in chemically defined media; optimize ratios with other BCAAs and aromatic amino acids.
Peptide synthesis (literature):
Small‑molecule derivatization (literature):
Chiral pool synthesis (literature):
Bioconjugation/Materials (literature):
Note: Manufacturer Applications field was not provided; the above expands typical laboratory uses consistent with the listed grades.
General literature guidelines (not item specifications):
Peptide coupling with Fmoc‑L‑Leu‑OH (solid phase):
Solution‑phase amide formation (unprotected leucine):
Esterification to methyl leucinate:
Transamination/BCAT assays (biochemical):
These are representative conditions from literature; optimize for scale, substrate scope, EHS profile, and downstream purification.
General laboratory guidance (literature/standard practice; not a substitute for SDS):
Applicability: L‑Leucine is a zwitterionic solid; solvent selection focuses on dissolution for solution prep, media, and coupling chemistry.
Polarity/miscibility (literature):
Practical choices:
Comparison to related BCAAs (literature): Leucine < isoleucine < valine in aqueous solubility at neutral pH; leucine is more hydrophobic than many polar amino acids, hence slower wetting and dissolution.
Always filter sterilize (0.22 µm) for cell culture; verify compatibility of co-solvents with cells or enzymes.
Item-specific (from Product Data):
General guidance (literature/best practice; not item specifications):
Reconstitution/solution prep:
Freeze–thaw: Dry solid is stable at RT as indicated; aqueous solutions should be aliquoted and stored refrigerated or frozen to maintain integrity and microbiological quality. Avoid repeated freeze–thaw of solutions.
Always consult the lot‑specific CoA/Spec Sheet for definitive storage limits, solution stability, and any additional handling instructions. Research use only (per Product Data).
Brief overview: L‑Leucine is a branched‑chain, proteinogenic α‑amino acid with an isobutyl side chain and one stereogenic center (L configuration).
Item-specific (from Product Data):
Literature/Computed (general reference values; not item specifications):
Structural features (descriptive):
L‑Leucine is a versatile chiral pool building block featuring an α‑amino and α‑carboxyl functional pair plus a hydrophobic isobutyl side chain.
Transformations (literature):
Stereochemical relay:
Materials/bioconjugation:
Practical tip: For solution‑phase couplings with unprotected leucine, form the hydrochloride salt (–NH3+Cl–) to suppress self‑condensation; use water‑miscible solvents (DMF/MeCN) and in situ activation to limit racemization.
Not applicable. This product is a small‑molecule amino acid, not an antibody, protein, or targeted biological reagent. No antigen/epitope, clone, isotype, or species reactivity information applies. For functional biological context, see the Biological Roles section.
Unser Leitfaden zur Qualitätsauswahl behandelt Reinheit, Stabilisatorstatus und Anwendungseignung für alle Varianten in unserem Katalog.
Animal Free Qualitätsleitfaden ansehen → USP Qualitätsleitfaden ansehen → JP Qualitätsleitfaden ansehen → Moligand™ Qualitätsleitfaden ansehen → Ph.Eur. Qualitätsleitfaden ansehen → for Cell culture Qualitätsleitfaden ansehen →